These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Are meningeal hemangiopericytoma and mesenchymal chondrosarcoma the same?: a study of HEY1-NCOA2 fusion. Fritchie KJ; Jin L; Ruano A; Oliveira AM; Rubin BP Am J Clin Pathol; 2013 Nov; 140(5):670-4. PubMed ID: 24124145 [TBL] [Abstract][Full Text] [Related]
3. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study. Syed M; Mushtaq S; Loya A; Hassan U Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222 [TBL] [Abstract][Full Text] [Related]
4. Desmin and myogenin reactivity in mesenchymal chondrosarcoma: a potential diagnostic pitfall. Gengler C; Letovanec I; Taminelli L; Egger JF; Guillou L Histopathology; 2006 Jan; 48(2):201-3. PubMed ID: 16405671 [No Abstract] [Full Text] [Related]
5. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Folpe AL; McKenney JK; Bridge JA; Weiss SW Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574 [TBL] [Abstract][Full Text] [Related]
6. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases. Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic involvement by mesenchymal chondrosarcoma harboring the HEY1-NCOA2 gene fusion. Cohen JN; Solomon DA; Horvai AE; Kakar S Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802 [TBL] [Abstract][Full Text] [Related]
8. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases. Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Santi M; Judkins AR; Rushing EJ Ann Diagn Pathol; 2010 Feb; 14(1):8-14. PubMed ID: 20123451 [TBL] [Abstract][Full Text] [Related]
9. Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis. Qi W; Rosikiewicz W; Yin Z; Xu B; Jiang H; Wan S; Fan Y; Wu G; Wang L J Pathol; 2022 Aug; 257(5):579-592. PubMed ID: 35342947 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Wang L; Motoi T; Khanin R; Olshen A; Mertens F; Bridge J; Dal Cin P; Antonescu CR; Singer S; Hameed M; Bovee JV; Hogendoorn PC; Socci N; Ladanyi M Genes Chromosomes Cancer; 2012 Feb; 51(2):127-39. PubMed ID: 22034177 [TBL] [Abstract][Full Text] [Related]
11. Detection of mesenchymal chondrosarcoma in pleural effusion with immunocytochemistry and determination of HEY1::NCOA2 fusion by next-generation sequencing on cell block. Zhong J; Wang Q; Xie Y; Niu Z; Zhou D Cytopathology; 2024 Jan; 35(1):149-152. PubMed ID: 37688410 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal chondrosarcoma diagnosed on FISH for HEY1-NCOA2 fusion gene. Moriya K; Katayama S; Onuma M; Rikiishi T; Hosaka M; Watanabe M; Hasegawa T; Sasahara Y; Kure S Pediatr Int; 2014 Oct; 56(5):e55-7. PubMed ID: 25336010 [TBL] [Abstract][Full Text] [Related]
13. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-NCOA2 fusion. Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896 [TBL] [Abstract][Full Text] [Related]
14. A mesenchymal chondrosarcoma with aberrant nuclear expression of STAT6: a potential diagnostic pitfall. Broggi G; Mazzucchelli M; Covello R; Casini B; Barbagallo GMV; Salvatorelli L; Magro G Pathol Res Pract; 2022 Apr; 232():153803. PubMed ID: 35217266 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: A clinicopathologic and molecular study of 13 cases with emphasis on diagnostic pitfalls. Xu B; Rooper LM; Dermawan JK; Zhang Y; Suurmeijer AJH; Dickson BC; Demicco EG; Antonescu CR Genes Chromosomes Cancer; 2022 Nov; 61(11):670-677. PubMed ID: 35672279 [TBL] [Abstract][Full Text] [Related]
16. Case report: A mesenchymal chondrosarcoma with alternative Kishikawa S; Kondo A; Yao T; Saito T Pathol Oncol Res; 2024; 30():1611730. PubMed ID: 39165647 [TBL] [Abstract][Full Text] [Related]
17. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561 [TBL] [Abstract][Full Text] [Related]
18. HEY1-NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice. Tanaka M; Homme M; Teramura Y; Kumegawa K; Yamazaki Y; Yamashita K; Osato M; Maruyama R; Nakamura T JCI Insight; 2023 May; 8(10):. PubMed ID: 37212282 [TBL] [Abstract][Full Text] [Related]
19. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases. Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330 [TBL] [Abstract][Full Text] [Related]
20. Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma. Nakayama R; Miura Y; Ogino J; Susa M; Watanabe I; Horiuchi K; Anazawa U; Toyama Y; Morioka H; Mukai M; Hasegawa T Pathol Int; 2012 Dec; 62(12):823-6. PubMed ID: 23252872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]